Platelet-rich plasma (PRP) shows up in a lot of hair loss marketing as a cutting-edge, "your own blood" regenerative treatment. The reality is more nuanced: the evidence does support a real, modest effect for some patients — but it's a smaller, less standardized evidence base than FDA-approved options like finasteride and minoxidil, and it comes at a real cost with no insurance coverage. Here's what the actual studies show.
What PRP actually is
PRP is an autologous blood product — made from your own blood, not a manufactured drug. A clinician draws venous blood, mixes it with an anticoagulant, and processes it (usually by centrifuging) to concentrate the platelets into a smaller volume of plasma. For hair loss specifically, that concentrated plasma is then injected across multiple sites in thinning areas — commonly the frontal scalp, part line, crown, and vertex.
There's no single standardized PRP product.Studies vary widely in blood volume drawn, centrifuge speed, single-spin vs. double-spin preparation, resulting platelet concentration, whether white blood cells are included, use of activating agents, injection depth and volume, and treatment frequency. This variability matters — it's a big part of why the research is harder to interpret than a standardized drug trial.
The proposed mechanismcenters on growth factors released when concentrated platelets activate in the scalp — including platelet-derived growth factor, vascular endothelial growth factor, insulin-like growth factor 1, epidermal growth factor, and transforming growth factor beta. Lab studies suggest these may support dermal papilla cell activity, blood vessel formation, cell survival, and a longer growth (anagen) phase. But this is proposed biology, not proof of a reliable clinical effect — and the picture is more complicated than "more growth factors, more hair." One lab study found that platelet factor 4, a PRP component, actually inhibited hair follicle growth under experimental conditions.
Regulatory status
PRP is not FDA-approved as a drug or biologic for androgenetic alopecia or scalp hair loss. This is worth being precise about, because clinics sometimes blur an important distinction:
- Some of the devices used to prepare PRP (centrifuges, separator kits) are FDA-cleared — but usually for different purposes entirely, like mixing PRP with bone grafts or specific wound-care uses, not scalp injection for hair loss.
- FDA clearance of the processing device is not the same as FDA approval of PRP injections as an effective hair loss treatment. A clinic using an FDA-cleared centrifuge doesn't mean the hair-loss procedure itself has been reviewed and approved for that purpose.
The accurate way to describe PRP for hair loss: it's an off-label procedural useof an autologous blood product. It hasn't gone through the same product-specific efficacy review that an FDA-approved drug like finasteride or minoxidil has.
What the clinical evidence shows
Multiple meta-analyses have looked at PRP for androgenetic alopecia, and the pattern across them is fairly consistent — a real but modest effect, with real limitations in study quality:
| Review | Sample | Finding |
|---|---|---|
| 2024 systematic review/meta-analysis | 14 RCTs, 431 patients | +27.55 hairs/cm² vs. control; rated low quality, ~96% statistical heterogeneity, evidence of publication bias |
| Separate meta-analysis | 10 trials | +~25 hairs/cm², no significant improvement in hair diameter; effect size was larger in smaller studies (a red flag for exaggerated benefit) |
| 2023 meta-analysis | 9 RCTs, 238 patients | Significantly higher density at 3 and 6 months vs. placebo; hair count/diameter improved from baseline but not significantly vs. placebo in pooled comparison |
| Earlier review | 30 studies, 687 patients | Most studies reported benefit; pooled RCTs showed increased density and thickness — but authors called for more standardized, lower-bias trials |
| Women-specific meta-analysis | 7 studies | Increased terminal-hair density, but no significant improvement in hair thickness; authors flagged need for replication in larger samples |
The 2024 review's finding is worth sitting with:the ~96% heterogeneity figure means the individual studies are producing quite different results from each other — a strong signal that "PRP works" can't yet be reduced to one reliable number.
The most defensible summary:PRP probably produces a modest average increase in hair density, generally in the range of roughly 20–30 additional hairs per square centimeter versus control — but what that means for any individual patient is genuinely uncertain, and there's no established optimal preparation, concentration, technique, or maintenance schedule yet.
How this compares to finasteride and minoxidil evidence
| PRP | Finasteride (pivotal trials) | Topical Minoxidil 5% (major trial) | |
|---|---|---|---|
| Sample size | 431 patients across 14 small studies (2024 review) | 1,553 men across 2 standardized trials | 393 men, single standardized trial |
| Product standardization | No standardized preparation across studies | Single standardized drug and dose | Single standardized formulation |
| Evidence quality rating | Very low (per network meta-analysis) | Higher, standardized outcome assessment | Higher, standardized outcome assessment |
Head-to-head against minoxidil specifically: a recent meta-analysis comparing PRP directly with topical minoxidil found no clear advantage for PRP on hair density, terminal hair count, or moderate-to-high regrowth rate — though patient satisfaction and pull-test results favored PRP in some analyses. PRP has not been shown to outperform standard medical therapy on the outcomes that matter most.
Mechanistically, they're also just different tools: finasteride suppresses the DHT pathway driving male-pattern loss, and minoxidil provides a standardized pharmacologic growth stimulus. PRP is a less standardized regenerative adjunct — it doesn't directly address the hormonal driver of androgenetic alopecia at all.
Protocol and cost
There's no universally accepted PRP schedule. Commonly used approaches include:
| Protocol | Schedule |
|---|---|
| Initial loading series | 3–4 initial sessions, roughly a month apart — the most common starting pattern in published studies |
| Year-one intensive protocol | Monthly for 3 months, then sessions at months 6, 9, and 12 (6 treatments in year one) |
| Loading + maintenance | 3 monthly loading sessions, then maintenance every 3–6 months |
Because androgenetic alopecia remains progressive and PRP doesn't address its genetic/hormonal drivers, ongoing maintenance is generally expected — but the ideal long-term interval hasn't been established in high-quality trials.
Cost:
| Source | Estimate |
|---|---|
| Harvard Health (earlier estimate) | ~$1,000 per session; initial series of 3 sessions common before assessing improvement |
| Harvard Health (more recent estimate) | ~$500–$1,500+ per session; common schedule of 3 monthly sessions + annual follow-up |
| Calculated initial series (3 sessions) | Roughly $1,500–$4,500 before any maintenance, based on the more recent range |
PRP is generally not covered by insurance.Costs vary widely because there's no uniform billing code, product, dose, or protocol across practices — geography, clinician specialty, and equipment all factor in, and there's no authoritative national price database to check against.
Using PRP alongside finasteride or minoxidil
PRP is more commonly framed in the dermatology literature as an adjunct, not a replacement — proposed protocols generally recommend continuing minoxidil, finasteride, or spironolactone alongside PRP, since PRP doesn't suppress the hormonal driver of the condition.
The combination evidence is more encouraging than PRP alone, though still limited:
- A 2024 meta-analysis (6 studies, 343 participants) found PRP + minoxidil outperformed either alone — roughly +9.14 hairs/cm² for density and +4.72 micrometers for diameter versus monotherapy
- A separate review of 5 RCTs found significantly greater density with PRP + minoxidil at 1, 3, and 5–6 months — though 3 of those trials carried a high risk of bias
- A small half-head trial studied PRP added on top of both minoxidil andfinasteride together — demonstrating the combination can be studied, but one small trial isn't enough to define an optimal regimen
Bottom line on combining: promising, but not definitive — small samples, short follow-up periods, and inconsistent PRP preparation make it hard to say precisely how much PRP adds on top of properly used finasteride or minoxidil alone. For more on how those two work together, see our guide on finasteride + minoxidil combination therapy.
An important practical note: PRP is an in-person procedure
Unlike finasteride or minoxidil, PRP can't be delivered remotely or mailed to you. It requires an in-person visit for blood draw, processing, and injection by a trained clinician. A telehealth provider could refer you to an affiliated in-person clinic, but the procedure itself isn't something a virtual-only visit can complete.
The evidence-based bottom line
PRP isn't a sham treatment — multiple meta-analyses point to a real, modest average improvement in hair density. But it's also not supported nearly as strongly as FDA-approved options: the studies are smaller, less standardized, and rated lower quality overall, and head-to-head comparisons haven't shown PRP outperforming minoxidil on the outcomes that matter most.
The most reasonable way to think about PRP:an optional, costly adjunct that may be worth considering if you want additional treatment on top of finasteride or minoxidil, can't tolerate a standard drug option, or have had an incomplete response to medication alone — as long as you go in understanding that protocols aren't standardized and long-term evidence is still limited.
FAQ
Q: Is PRP FDA-approved for hair loss?
No. It's an off-label use of an autologous blood product. Some processing devices are FDA-cleared, but that's not the same as FDA approval of PRP injections as a hair-loss treatment.
Q: Does PRP actually regrow hair?
The evidence suggests a modest average increase in hair density for some patients — commonly cited in the range of 20–30 additional hairs per square centimeter versus control — but individual results are uncertain and the underlying studies are rated low-to-very-low quality.
Q: Is PRP better than minoxidil or finasteride?
No — direct comparisons haven't shown PRP outperforming topical minoxidil on key outcomes like density or hair count. It's generally considered an adjunct, not a replacement.
Q: How much does PRP cost?
Published estimates range from roughly $500 to $1,500+ per session, with an initial series of 3 sessions often costing $1,500–$4,500 before any maintenance. It's typically not covered by insurance.
Q: Can I get PRP through telehealth?
No — it requires an in-person blood draw, processing, and injection. A telehealth provider might refer you to an affiliated clinic, but the procedure itself can't be done remotely.
Q: Should I do PRP instead of finasteride or minoxidil?
Current evidence doesn't support using PRP as a replacement for FDA-approved options. It's more reasonably considered as an addition to, not a substitute for, standard therapy — a conversation worth having with a provider given the cost and evidence limitations.
Talking to a provider about your options
If you're weighing PRP against or alongside finasteride and minoxidil, a provider can help you think through realistic expectations, cost, and whether it makes sense for your specific situation. Our Hair Loss Provider Match Quiz can help you find providers on our Hair Loss comparison hub who discuss the full range of options.
*This article is for informational purposes only and is not medical advice. RENVA is not a healthcare provider. PRP for hair loss is an off-label procedure with a limited, low-quality evidence base compared to FDA-approved treatments. Talk to a licensed provider about whether it's appropriate for you.*